Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection

A mouse is dying from a gut infection that its immune system would normally clear in a few weeks. The pathogen isn't novel. The dose isn't extraordinary. The only thing different is that this mouse is missing one nutrient signal — vitamin D. That absence didn't just slow the immune response; it killed the host. This is the finding that Lin and colleagues at Penn State set out to explain: not that vitamin D is broadly good for immunity, but that it sits at a specific, critical point in the gut's first line of defense. To understand what breaks, you first need to understand what normally works. Citrobacter rodentium is a gram-negative bacterium used as a laboratory model of gut infection because it colonizes the colon and reproduces key features of human infections with enterohemorrhagic and enteropathogenic E. coli — the kinds of bacteria responsible for serious foodborne illness in people. In healthy mice, C. rodentium infection peaks around days seven to fourteen, then clears by day thirty-five. But that clearance depends on a two-wave immune response. The second wave — T cells, B cells, antibodies — matters for full resolution. The first wave is what determines whether the host survives to launch the second. That first wave is led by group three innate lymphoid cells, or ILC3s. Think of them as tissue-resident sentinels in the gut wall — immune cells that don't need prior exposure to a pathogen to respond. They're already there, and they act fast. Their critical output is a cytokine called IL-22, a signaling molecule that tells gut epithelial cells to reinforce the intestinal barrier and produce antimicrobial factors. When IL-22 is absent, C. rodentium infection becomes lethal. The ILC3-to-IL-22-to-epithelial-defense pathway is the gut's immediate containment strategy — and it is the pathway that vitamin D deficiency dismantles. Vitamin D's role in immunity isn't just the calcium and bone story. Immune cells express the vitamin D receptor, and cells like macrophages and dendritic cells carry the enzyme Cyp27B1, which converts the circulating form of vitamin D — 25-hydroxyvitamin D — into its high-affinity active form, 1,25-dihydroxyvitamin D, or 1,25D for short. That active form binds the vitamin D receptor, which then acts as a nuclear transcription factor, directly regulating gene expression in immune cells. So the immune system doesn't just respond to vitamin D passively; it processes and activates it locally. To probe this, Lin and colleagues built two key genetic mouse models. Cyp27B1 knockout mice, referred to as Cyp KO, cannot convert vitamin D into 1,25D. When these mice are also fed a vitamin D-deficient diet, they have essentially no functional vitamin D signal: the residual 25-hydroxyvitamin D in their circulation isn't present at concentrations high enough to activate the receptor. Wild-type mice fed the same deficient diet can still make some 1,25D from whatever vitamin D remains in their system, giving them a partial signal. The team also used Rag knockout mice, which lack T and B cells entirely, to isolate the innate immune arm of the response. These three models — deficient wild-type, Cyp KO, and Rag KO — became the architecture of the experiment. The finding that connected vitamin D to ILC3s came before the infection experiments even began. Vitamin D-deficient mice, both wild-type and Cyp KO, had fewer ILC3 cells in the colon and produced less IL-22 than vitamin D-sufficient controls. The vitamin D receptor gene was expressed at higher levels in the RORγt-positive ILC3 population — the transcription factor that defines these cells — than in other innate lymphoid cell types. Vitamin D wasn't incidentally involved; it was specifically enriched as a signal in exactly the cells that matter most for early gut defense. Then came the infection. Lin and colleagues gavaged mice with five billion colony-forming units of C. rodentium and tracked weight, bacterial shedding, tissue colonization, and survival. The results form a clear gradient of vulnerability. Vitamin D-deficient wild-type mice survived, but they cleared the infection significantly more slowly — showing roughly one hundred-fold higher fecal bacterial counts at day twenty-one compared to sufficient controls, with greater bacterial loads in the spleen and liver by day fourteen. Their serum 25-hydroxyvitamin D was below twenty nanograms per milliliter — the threshold for deficiency. They had a functional deficit, but their residual 1,25D production kept them alive. Vitamin D-deficient Cyp KO mice, with no 1,25D at all, developed fulminant disease. Significant weight loss, severe colonic inflammation and epithelial hyperplasia on histology, and premature death — with about a third of the animals requiring sacrifice by day fourteen due to excessive weight loss. Vitamin D-deficient Rag KO mice — which have no T cells, no B cells, only innate immunity — died within two days of infection. Sixty-seven percent of vitamin D-deficient Rag KO mice died within forty-eight hours, compared to only fourteen percent of vitamin D-sufficient Rag KO mice. The mice that died had high C. rodentium counts in their liver and spleen, confirming systemic infection. This result is decisive. When you remove adaptive immunity entirely, the difference between surviving and dying early comes down to vitamin D status and the ILC3s it regulates. There are no other variables left. This is where the paper gets structurally elegant. Lin and colleagues didn't just demonstrate an association; they reversed it in three different ways, each one isolating a different node in the causal chain. First: give the missing cytokine directly. Treating vitamin D-deficient Cyp KO mice with an IL-22 Fc fusion protein — a stabilized form of IL-22 — produced one hundred percent survival to day fourteen, compared to death in the untreated deficient Cyp KO group. If the downstream effector is supplied, the upstream deficiency in 1,25D doesn't matter. That tells you IL-22 is the critical output. Second: restore the active vitamin D hormone and see if the ILC3 compartment rebuilds. When Lin and colleagues gave 1,25D to vitamin D-deficient wild-type mice starting at three weeks of age, colonic ILC3 frequencies rose to match vitamin D-sufficient levels, IL-22 secretion increased, and the mice cleared C. rodentium faster. Starting the same treatment at six weeks of age did not recover ILC3 frequencies. There's a developmental window — ILC3s in the colon normally peak by four weeks — during which vitamin D signaling appears to be required for the cells to establish themselves. Miss that window, and simply restoring the hormone later isn't enough. Third: give IL-22 directly to vitamin D-deficient wild-type mice and watch whether vitamin D still matters. It didn't. Vitamin D-deficient mice treated with IL-22 Fc cleared C. rodentium by day thirty-five just like sufficient controls, while untreated vitamin D-deficient mice still shed approximately one hundred-fold more bacteria at that point. Exogenous IL-22 bypassed the entire vitamin D requirement for infection clearance. Together, these three rescue arms close the argument. Vitamin D is required for maintaining the ILC3 population that produces IL-22. IL-22 is the functional output that protects the gut. Supply IL-22 directly, and vitamin D becomes dispensable. Supply 1,25D during the right developmental window, and ILC3s recover along with protective function. Remove both, and the host dies. Lin and colleagues are using C. rodentium as a stand-in for human enteropathogenic and enterohemorrhagic E. coli infection. The immune pathway they've mapped — vitamin D driving 1,25D and vitamin D receptor signaling in colonic ILC3s, ILC3s producing IL-22, and IL-22 fortifying the epithelial barrier — is conserved enough that these mouse findings carry direct mechanistic relevance for human gut immunity. Vitamin D deficiency is common globally, and gut infections remain a leading cause of morbidity and mortality, particularly in young children. The developmental timing finding is especially worth sitting with: vitamin D appears to shape the ILC3 compartment during early life, which means that deficiency during that window could have lasting consequences for gut immune competence that persist even after vitamin D status is restored. The precise molecular mechanism — whether 1,25D acts directly on ILC3 development, on IL-22 gene expression, or on upstream signals like Notch — remains to be worked out. But the causal chain itself is now established. Vitamin D up, ILC3s up, IL-22 up, gut protected. Vitamin D gone, that chain breaks at its first link, and the gut's earliest defense against bacterial colonization collapses with it. This lecture was created by ennepō. Go to https://ennepo.ai to Discover, Create and Follow the latest research in your field. Read when you can. Listen when you want to.